[1] Zhang A, Yin C, Wang Z, et al. Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma[J]. J of Int Med Res, 2016, 44(6):1414.
[2] 徐伟红.血清GP73、AFP-L3、AFP及AFU检测在原发性肝癌诊断中的应用评价[J].中华检验医学杂志,2016,39(4):262.
[3] Broadhurst P, Toyoda H, Kumada T, et al. Prognostic impact of serum alpha-fetoprotein in patients with hepatocellular carcinoma: an international collaborative study[J]. J of Hepatology, 2017, 66(1):S620-S621.
[4] 余明杰,王萍,韩媛媛,等.肝功能指标及肝纤维化标志物在乙型肝炎患者中的测定意义研究[J].中华医院感染学杂志,2017,27(13):2912-2915.
[5] 陆兴热.AFP、GP73、SOD联合检测在原发性肝癌患者诊断中应用价值[J].中国普通外科杂志,2016,25(7):1076-1080.
[6] Weaver M, Sharma Y, Vachharajani N, et al. Mo1516 Serum Alpha-Fetoprotein Level Per Total Tumor Volume as a Predictor of Hepatocellular Carcinoma Recurrence Following Resection[J]. Gastroenterology, 2016, 150(4):S1137-S1138.
[7] 刘景峰,田领.海藻酸钠微球在原发性肝细胞肝癌经皮肝动脉化疗栓塞治疗中的应用[J].山东医药,2017,57(18):36-38.
[8] 赵鹏,郑加生,张洪海,等.肝动脉导管化疗栓塞联合CT引导精准微波消融治疗原发性肝癌的疗效及影响因素[J].中华肿瘤杂志,2016,38(2):138-145. |
2018, Vol. 35 
